Obesity and Low-Grade Inflammation Increase Plasma Follistatin-Like 3 in Humans
Figure 1
Plasma follistatin-like 3 in subjects with different glucose tolerance and in nonobese and obese subjects. (a) Plasma follistatin-like 3 (fstl3) subdivided by glycemic status (CON, ), impaired glucose tolerance (IGT, ), and patients with type 2 diabetes (T2DM, ). (b) Plasma fstl3 in obese () and nonobese subjects (). (c) Subdividing the control (obese = 36; nonobese = 42), (d) the impaired glucose tolerant (obese = 39; nonobese = 19), and (e) patients with type 2 diabetes (obese = 28; nonobese = 36). Boxplot showing median value of plasma fstl3 with 25th and 75th quartiles whiskers represents maximum and minimum value of fstl3. ** indicates . *** indicates .
